Erste Asset Management GmbH Raises Stock Position in DaVita Inc. (NYSE:DVA)

Erste Asset Management GmbH boosted its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 757.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,000 shares of the company's stock after acquiring an additional 21,200 shares during the quarter. Erste Asset Management GmbH's holdings in DaVita were worth $3,733,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in DVA. SBI Securities Co. Ltd. bought a new stake in DaVita during the 4th quarter worth approximately $41,000. Quarry LP bought a new stake in shares of DaVita in the 3rd quarter valued at $60,000. Venturi Wealth Management LLC boosted its stake in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after purchasing an additional 152 shares during the last quarter. Versant Capital Management Inc boosted its stake in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Blue Trust Inc. boosted its stake in shares of DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after purchasing an additional 131 shares during the last quarter. 90.12% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently commented on DVA shares. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. Cowen reaffirmed a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Barclays boosted their target price on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, DaVita currently has an average rating of "Hold" and a consensus target price of $166.33.

Remove Ads

DaVita Stock Performance

DVA traded up $0.63 during trading on Wednesday, hitting $150.00. 960,969 shares of the company traded hands, compared to its average volume of 924,455. The firm has a market cap of $12.00 billion, a P/E ratio of 13.97, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The stock's fifty day moving average is $158.80 and its 200 day moving average is $157.61. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.